1. Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data. Issue 3 (June 2014) Authors: Hoste, J.; Daci, E.; Mathieu, C. Journal: Acta clinica belgica Issue: Volume 69:Issue 3(2014) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data. Issue 3 (June 2014) Authors: Hoste, J.; Daci, E.; Mathieu, C. Journal: Acta clinica belgica Issue: Volume 69:Issue 3(2014) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗